GLP-1 receptor agonist — chronic weight management
Generic name: semaglutide 2.4 mg (injection)
US Retail Price
$1,300–$1,500/month
With copay card: As low as $25/month (commercially insured, if covered)
Manufacturer
Novo Nordisk
Used For
Chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related comorbidity; cardiovascular risk reduction in obese/overweight adults with CVD
Many insurance plans, including most Medicare Part D plans, do NOT cover Wegovy for weight loss. Coverage is improving as Wegovy gained a cardiovascular indication (SELECT trial). Always verify your insurance coverage before starting. International pharmacies currently offer the most significant savings for uninsured or uncovered patients.
Novo Nordisk offers a savings card that can reduce Wegovy to as low as $25/month for eligible commercially insured patients whose insurance covers Wegovy. Not valid for Medicare/Medicaid.
Apply for Wegovy Savings CardVerified international pharmacies sell Wegovy (semaglutide 2.4 mg) for significantly less than US retail. This is often the best option for patients without insurance coverage.
Compare International PricesNovo Nordisk offers patient assistance for those who meet income requirements. Search NeedyMeds for the Wegovy PAP application.
Search Wegovy PAP on NeedyMedsGoodRx coupons are available for Wegovy at some pharmacies. Savings vary — check GoodRx for the current lowest price near you.
Check GoodRx PriceLooking for another medication?
The Med Map covers all 8 categories of savings options for hundreds of drugs.
Back to The Med Map